Injective vs Solana — how do they compare? Injective trades at Rp81,151 (market cap Rp8,11T, Rp759,33M 24h volume), while Solana trades at Rp1,351,091 (market cap Rp787,88T, Rp21,62T 24h volume). The key difference: Solana is far larger — about 97.1× Injective's market cap, and Injective's circulating supply is 100M INJ versus 582,6M SOL for Solana. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Solana for 68 Days on average.
| INJ | SOL | |
|---|---|---|
Market Cap | Rp8,11T | Rp787,88T |
Volume (24h) | Rp759,33M | Rp21,62T |
Circulating Supply | 100M INJ | 582,6M SOL |
Typical Hold Time | 37 Days | 68 Days |
Signals from Pluang's Aura AI — not financial advice
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Solana is currently trading at Rp1,349,132 with a market cap of Rp787.88T, showing bullish technical signals with moving averages supporting upward momentum. The asset is positioned between key support at Rp1,346,132 and resistance at Rp1,371,748, with RSI_6 at 83.91 indicating potential overbought conditions. Recent ecosystem growth includes SOL Strategies surpassing 31,000 unique wallets and 4 million SOL in assets under delegation, while launching a liquid staking platform that enhances network utility.
Overall outlook remains cautiously optimistic with strong technical momentum but elevated RSI levels suggesting near-term consolidation risk. Key opportunities include growing institutional adoption and expanding DeFi ecosystem, while major risks involve regulatory uncertainty and high volatility typical of crypto assets. Investors should monitor support levels closely for entry points.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →SOL is the native token of Solana, an open source project which implements a new, high-performance, permission less blockchain. It is also the fastest blockchain in the world and the fastest growing ecosystem in crypto, with over 400 projects spanning DeFi, NFTs, Web3 and more. The architecture of their blockchain are build based on Proof of History (PoH); a proof for verifying order and passage of time between events.
Read more on SOL →